Risk factors associated with ceftazidime-resistant Klebsiella pneumoniae infection;Factores de riesgo asociados a infecciones por Klebsiella pneumoniae resistentes a ceftacidima

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 2, 2003, Pages 72-76

  Bermejo, Joaquín ^a   Lesnaberes, Patricia ^a   Arnesi, Nora ^a   Gianello, Mariano ^a   Notario, Rodolfo ^a   Borda, Noemí ^a   Gambandé, Telma ^a   Bencomo, Blanca ^a  

^a HOSPITAL ESPAÑOL   (Argentina)

Author keywords

Extended spectrum beta lactamase; Klebsiella pneumoniae; Risk factors

Indexed keywords

AMINOPENICILLIN; BETA LACTAMASE INHIBITOR; CEFALEXIN; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROBACTER INFECTION; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION CONTROL; INFECTION RISK; KLEBSIELLA PNEUMONIAE; LOGISTIC REGRESSION ANALYSIS; MALE; NONHUMAN; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0037293638     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13042862     Document Type: Article

References (25)

1. Sirot D, Sirot J, Labia R, Moraud A, Courvalin P, Darfeuille-Michaud A, et al. Transferable resistance to third generation cephalosporins in clinical isolates of Kebsiella pneumoniae: Identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother 1987;20:323-34.
2. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Dural J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987;2:302-6.
3. Harris AD, Karchmer TB, Carmeli Y, Samore M. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review. Clin Infect Dis 2001;32:1055-61.
4. Schiappa DA, Hayden MK, Matushek MG, Hashemi FN, Sullivan J, Smith KY, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation. J Infect Dis 1996;17:529-36.
5. Peña C, Pujol M, Ricart A, Ardanuy C, Ayats J, Liñares J, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 1997;35:9-16.
6. Asensio A, Oliver A, González-Diego P, Baquero F, Pérez-Díaz JC, Ros P, et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000;30:55-60.
7. Arpin C, Rogues AM, Kabouche S, Boulard G, Quesnel C, Gachie JP, et al. Prospective survey of colonization and infection caused by SHV-4 producing Klebsiella pneumoniae in a nenrosurgical intensive care unit. Epidemiol Infect 2000;124:401-8.
8. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517-23.
9. Farmer III JJ. Enterobacteriaceae: Introduction and identification. En: Murray PR, editor. Manual of Clinical Microbiology. Washington: ASM Press, 1995; p. 438-49.
10. National Committee for Clinical Laboratory Standards. M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, 2002.
11. Legrand P, Fournier G, Bure A, Jarlier V, Nicolás MH, Decre D, et al. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four french hospitals. Eur J Clin Microbiol Infect Dis 1989;8:527-9.
12. Garner JS, Jarvis WR, Emori TG, Horau TC, Hughes JM. Center for Diseases Control definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
13. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum (β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162-71.
14. Meyer KS, Urban C, Eagan JA, Berger BJ, Rohal JJ. Nosocomial outbreaks of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353-8.
15. Rice LB, Willey SH, Papanicolau GA, Medeiros AA, Eliopoulos GM, Moellering RC, et al. Outbreak of ceftazidime resistance caused by extended spectrum beta-lactamases at a Massachusetts chronic-case facility. Antimicrob Agents Chemother 1990;34:2193-9.
16. Naumovski L, Quinn JP, Miyashiro D, Patel M, Bus K, Singer SB, et al. Outbreak of ceftazidime resistance due to novel extended-spectrum beta-lactamasas in isolates from cancer patients. Antimicrob Agents Chemother 1992;36:1991-6.
17. Casewell M, Phillips I. Hands as a route of transmission for Klebsiella species. BMJ 1977;2:1315-7.
18. Selden R, Lee S, Wang WL, Bennett JV, Eickhoff TC. Nosocomial Klebsiella infections: Intestinal colonization as a reservoir. Ann Intern Med 1971;74:657-64.
19. Lucet JC, Chevret S, Vanjak D, Decre D, Macrez A, Bedos JP, et al. Risk factors for acquiring extended-spectrum beta-lactamases Enterobacteriaceae in ICU. 1992. Abstract 637. Program and Abstract of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington: American Society for Microbiology, 1992.
20. Piroth L, Aube H, Doise JM, Vincent-Martin M. Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis 1998;27:81-3.
21. Peña C, Pujol M, Ardanuy C, Ricart A, Pallarés R, Liñares J, et al. Epidemiology and succesful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42:53-8.
22. Patterson JE, Hardin TC, Kelly CA, García R, Jorgensen JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2000;21:455-8.
23. Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goosens H, Von Gottberg A, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended spectrum beta lactamase production in K. pneumoniae isolates causing bacteremia. Clin Infect Dis 2000;30:473-8.
24. Courvalin P, Trieu-Cuot P. Minimizing potencial resistance: The molecular view. Clin Infect Dis 2001;33(Suppl 3):S138-46.
25. Martínez-Martínez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998;351:797-9.